CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
A mobile health platformdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03436082
NCT03436082N/ACompleted

Post-Market Surveillance With a Novel mHealth Platform

Yale University·observational·Posted Feb 19, 2018·Updated Mar 19, 2021

In Brief

An observational study evaluating A mobile health platform for Gastrectomy and Atrial Fibrillation. Completed, enrolled 60 participants across 2 sites.

Detailed Summary

This is a study to pilot the feasibility of using a novel patient-led, smartphone-based mobile health platform (Hugo) for real-world surveillance of outcomes of patients after they undergo a bariatric surgical procedure (either sleeve gastrectomy or gastric bypass) and catheter-based atrial fibrillation ablation

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 19, 2018
Enrollment StartJan 26, 2018
Primary CompletionDec 25, 2018
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 8.4 years ago

Interventions

A mobile health platformdevice

Patients pilot testing the smartphone based, mobile health platform called HUGO. Patients will also be given syncable devices to use that will provide additional insights into their health and health outcomes.Patients will be queried about specific symptoms related to their procedure at enrollment, one week post-procedure, at 4 weeks and again at 8 weeks.